Spherocytosis physical examination

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Spherocytosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Spherocytosis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Spherocytosis physical examination On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Spherocytosis physical examination All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Spherocytosis physical examination
CDC on Spherocytosis physical examination
Spherocytosis physical examination in the news
Blogs on Spherocytosis physical examination
Directions to Hospitals Treating Spherocytosis
Risk calculators and risk factors for Spherocytosis physical examination

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Physical Examination

Acute cases can threaten hypoxemia through anemia and acute kernicterus through hyperbilirubinemia, particularly in newborns.

In chronic cases anemia and splenomegaly, or enlargement of the spleen due to its increased activity. In some cases the spleen continues to change sizes. Yet in other cases the spleen just continues growing which puts the patient at a greater risk for rupture, which can cause death. Furthermore, the detritus of the broken-down blood cells--bilirubin--accumulates in the gallbladder, and can cause gallstones or "sludge" to develop.